Bulog targets 828,000 tons of SPHP rice distribution in 2026

Jakarta, April 3 -- State logistics agency Bulog said the rice distribution under the food price and supply stabilization (SPHP) program will be carried out throughout 2026 with a target of 828 thousa... Read More

Malay Mail's top 10 picks: Malaysian film 'Malaikat Malam' takes the lead in No.1, speeding past sci-fi hit 'Project Hail Mary' at the local box office

KUALA LUMPUR, April 3 -- Collecting an impressive RM10.2 million from early screenings and its first week, local film Malaikat Malam has surged to No. 1 at the Malaysian box office. In an unexpected ... Read More

Nine suspects arrested over homicide in Mattakkuliya

Sri Lanka, April 3 -- A total of nine suspects were arrested yesterday (April 2) by the Sri Lanka Police in connection with the fatal stabbing of an individual in the Mattakkuliya area. The homicide ... Read More

Govt halts divestment of eight major SOEs, SC informed

Sri Lanka, April 3 -- The Attorney General's Department has informed the Supreme Court of Sri Lanka that the incumbent government will not proceed with the previous government's decision to divest eig... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More

Singapore Clinical Trial: A Phase 1, Open-Label, Single Dose Study to Investigate the Relative Bioavailability, Safety, and Tolerability of Two Formulations of Eltrekibart in Healthy Participants

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Single Dose Study to Investigate the Relative Bioavailability, Safety, and ... Read More

Singapore Clinical Trial: ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In Combination with Ipilimumab in Participants with First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC)

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In ... Read More

Singapore Clinical Trial: Phase II Open-label Study Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'Phase II Open-label Study Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopha... Read More

Singapore Clinical Trial: A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)ide Analogue-treated Participants with HBeAg Negative Chronic Hepatitis B in the Asia Pacific Region

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 ... Read More

• ««
• «
• 8524
• 8525
• 8526
• 8527
• 8528
• 8529
• 8530
• 8531
• 8532
• 8533
• »
• »»